Revance Therapeutics logo
Revance Therapeutics RVNC
$ 3.75 -2.47%

Quarterly report 2024-Q3
added 11-07-2024

report update icon

Revance Therapeutics Long Term Debt Current 2011-2024 | RVNC

Annual Long Term Debt Current Revance Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
5.7 M 4.24 M 4.75 M 4.44 M 3.47 M - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
5.7 M 3.47 M 4.52 M